Zhu et al. [52] found that bufalin, the main compound of cinobufotalin injection, induces apoptosis of lung cancer cells in a dose- and time-dependent manner by upregulating Bax expression and downregulating BCL-2, thereby blocking the activation of AKT. The gene discussed is BCL2; the disease is lung carcinoma.